Clinical Trial Update: QL1706 Combined With SOX Used in Theperioperative Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating QL1706 in combination with the SOX chemotherapy regimen as perioperative treatment for gastric cancer and esophagogastric …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Cancer
• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• QL1706
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Xiangdong Cheng | Conditions: Gastric Cancers, Esophagogastric Junction Cancers | Phase 1, Phase 2 | Status: RECRUITING